ACTRIMS 2023 | Phenotyping the prodrome could lead to earlier recognition of MS

Anibal Chertcoff, MD, PhD, The University of British Columbia, Vancouver, Canada, explains how findings from a study assessing the presence and relative burden of psychiatric morbidity in patients with multiple sclerosis in the five years prior to MS onset can help characterize the MS prodrome. During the MS prodrome, there are a number of symptoms that individuals with MS may present before developing the typical MS symptoms that will lead to a diagnosis of MS. A better understanding of the MS prodrome could have important clinical implications as it could enable earlier recognition of MS and earlier initiation of treatments that reduce relapse rates and long-term disability. This interview took place at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2023 in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.